Preclinical studies in murine models showed significant reductions in visceral adiposity and improvements in insulin sensitivity independent of caloric restriction
Advanced age, hypertension, dyslipidemia, and diabetes are recognized risk factors for CKD (Table 5)
- April 23, 2025 - AM-PR The extensive body of research from Mayo Clinic emphasizes major advancements in obesity, including prediction of GLP-1 side effects, a new obesity sub-phenotype, and insights into personalized bariatric and endoscopic procedures
These medications are changing the game for Type 2 diabetes and long-term weight management but they work differently, and the right choice depends on your personal goals
[DOI] [PMC free article] [PubMed] [Google Scholar] 193.Khalily MP, Soydan M